• ثبت نام
    • ورود به سامانه
    مشاهده مورد 
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 12, Issue 4
    • مشاهده مورد
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 12, Issue 4
    • مشاهده مورد
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Resveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities

    (ندگان)پدیدآور
    MOKNI, MeherziaHamlaoui, SoniaKarkouch, InesAmri, MohamedMarzouki, LamjedLimam, FeridAouani, Ezzedine
    Thumbnail
    دریافت مدرک مشاهده
    FullText
    اندازه فایل: 
    2.197 مگابایت
    نوع فايل (MIME): 
    PDF
    نوع مدرک
    Text
    Research article
    زبان مدرک
    English
    نمایش کامل رکورد
    چکیده
    In this study, we investigated the cardioprotective effects of resveratrol. Rats were intraperitoneally administered with resveratrol (25 mg/kg bw) or vehicle (ethanol 10%) for 7 days and their heart subjected to ischemia/reperfusion injury. Isolated hearts were langendorff perfused, left ventricular functions as heart rate and developed pressure, as well as, heart antioxidant status were determined. Data showed that resveratrol improved recovery of post-ischemic ventricular functions when compared to control. Resveratrol also improved myocardial lipoperoxidation, free iron and antioxidant enzyme activities. Resveratrol decreased significantly catalase while it increased peroxidase and superoxide dismutase activities. In this later case, native PAGE analysis of superoxide dismutase isoforms revealed that resveratrol up regulated iron and manganese isoforms. Resveratrol exerted potential cardioprotection partly by its antioxidant properties.
    کلید واژگان
    Resveratrol
    Heart
    Ischemia/reperfusion injury
    MDA
    Free iron
    Catalase
    Superoxide dismutase
    Peroxidase
    Antioxidant enzyme isoforms
    Pharmacotherapy (Clinical Pharmacy)

    شماره نشریه
    4
    تاریخ نشر
    2013-11-01
    1392-08-10
    ناشر
    School of Pharmacy, Shahid Beheshti University of Medical Sciences
    سازمان پدید آورنده
    Neurophysiology Laboratory and Functional Pathology, Department of Biological Sciences, Faculty of Sciences of Tunis, University Campus of Al-manar, Tunisia, Tunis.
    Neurophysiology Laboratory and Functional Pathology, Department of Biological Sciences, Faculty of Sciences of Tunis, University Campus of Al-manar, Tunisia, Tunis.
    Bioactive Substance Laboratory, Biotechnology Centre, Technopolis Borj-Cedria, BP-901, 2050 Hammam-Lif, Tunis.
    Neurophysiology Laboratory and Functional Pathology, Department of Biological Sciences, Faculty of Sciences of Tunis, University Campus of Al-manar, Tunisia, Tunis.
    Neurophysiology Laboratory and Functional Pathology, Department of Biological Sciences, Faculty of Sciences of Tunis, University Campus of Al-manar, Tunisia, Tunis.
    Bioactive Substance Laboratory, Biotechnology Centre, Technopolis Borj-Cedria, BP-901, 2050 Hammam-Lif, Tunis.
    Bioactive Substance Laboratory, Biotechnology Centre, Technopolis Borj-Cedria, BP-901, 2050 Hammam-Lif, Tunis.

    شاپا
    1735-0328
    1726-6890
    URI
    https://dx.doi.org/10.22037/ijpr.2013.1404
    http://ijpr.sbmu.ac.ir/article_1404.html
    https://iranjournals.nlai.ir/handle/123456789/313068

    مرور

    همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

    حساب من

    ورود به سامانهثبت نام

    آمار

    مشاهده آمار استفاده

    تازه ترین ها

    تازه ترین مدارک
    © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
    تماس با ما | ارسال بازخورد
    قدرت یافته توسطسیناوب